2Moreno N, Mendez-Echevarria A, de Inocencio J, Del Castillo F, Baquero-Artigao F, Garcia-Miguel MJ, et al. Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin[ J]. Pediatr Cardiol, 2008, 29 (1) : 31-35.
4Chang FY,Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH. Characteristics of Kawasaki disease in infants younger than six months of age[ J ]. Pediatr Infect Dis J, 2006, 25 (3) : 241-244.
5Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease : a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease[J]. Circulation, 2004, 110(17): 2747-2771.
6Nakano H, Ueda K, Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease[ J]. Am J Cardiol, 1985, 56(13) : 846-851.
7Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Pediatr Int, 2005, 47(6) : 711-732.
8Wallace CA, French JW, Kahn S J, Sherry DD. Initial intravenous gammaglobulin treatment failure in kawasaki disease [ J]. Pediatrics, 2000, 105(6) :1-4.
9Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulln-resistant Kawasaki disease with pulsed doses of corticosteroids[J]. J Pediatr, 1996, 128(1): 146-149.
10Minich LL, Sleeper LA, Atz AM, McCrindle BW, Lu M, Colan SD, et al. Delayed diagnosis of Kawasaki disease: what are the risk factors? [ J]. Pediatrics, 2007, 120(6) : e1434-e1440.
二级参考文献15
1Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation, 2004, 110: 2747-2771.
2KY, Hong JH, Han JW, et al. Features of Kawasaki disease at the extremes of age. J Paediatr Child Health, 2006, 42 : 423- 427.
3Chang FY, Hwang B, Chen SJ, et al. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J, 2006, 25 : 241-244.
4Bums JC, Wiggins JW Jr, Toews WH, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr, 1986, 109:759-763.
5Biezeveld MH, Geissler J, Weverling GL, et al. Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease. Arthritis Rheum, 2006, 54:369-376.
6Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr, 2006, 149: 237-240.
7Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin [J]. N Engl J Med, 1986, 315(6): 341-347.
8Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose [J]. J Pediatr, 1997, 131(6): 888-893.
9Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children [J]. Circulation, 1993, 87(5): 1776-1780.
10Rowley AH, Shulman ST. Kawasaki Disease [A]. In: Behrman RE, Kliegman RM, Arvin AM, eds. Nelson Textbook of Pediatrics [M]. 16th ed. Philadeiphia: Saunders, 2000, 725-727.
